albuterol has been researched along with Body Weight in 33 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seven children from 3 to 14 years old with chronic steroid-dependent asthma were treated with methotrexate (MTX)." | 7.68 | Methotrexate treatment of severe asthma in children. ( Guss, S; Portnoy, J, 1992) |
| "Plasma cholesterol, plasma and white blood cell ascorbic acid concentrations were estimated in 30 untreated, 32 salbutamol-treated patients with bronchial asthma and in 57 normal controls." | 7.66 | Plasma and white blood cell ascorbic acid concentrations in patients with bronchial asthma. ( Iboko, MI; Jessop, WJ; Ojutiku, OO; Olusi, SO, 1979) |
| "To determine whether adiposity worsens the clinical and physiological manifestations of acute asthma and limits therapeutic effectiveness of standard treatment, we contrasted signs, symptoms, medication use, arterial oxygen saturation, peak expiratory flow rate, and the bronchodilator response to standard doses of albuterol in 90 non-obese and 90 obese asthmatics as they presented for urgent care." | 5.15 | Impact of obesity on the severity and therapeutic responsiveness of acute episodes of asthma. ( Coreno, AJ; Dickey-White, H; McFadden, ER; Seitz, RE; Skowronski, ME; Villalba, KD; Yeh, KH, 2011) |
| "Seven children from 3 to 14 years old with chronic steroid-dependent asthma were treated with methotrexate (MTX)." | 3.68 | Methotrexate treatment of severe asthma in children. ( Guss, S; Portnoy, J, 1992) |
| "Plasma cholesterol, plasma and white blood cell ascorbic acid concentrations were estimated in 30 untreated, 32 salbutamol-treated patients with bronchial asthma and in 57 normal controls." | 3.66 | Plasma and white blood cell ascorbic acid concentrations in patients with bronchial asthma. ( Iboko, MI; Jessop, WJ; Ojutiku, OO; Olusi, SO, 1979) |
| "At weeks 0, 4, 8, and 12, spirometry was performed predose and serially over 6 h after dosing with study drug." | 2.69 | Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics. ( Bleecker, ER; Colice, GL; Ekholm, BP; Klinger, NM; Ramsdell, J; Slade, HB; Tinkelman, DG, 1998) |
| "Albuterol was nebulized using a vibrating mesh nebulizer and the percentage inhaled dose was determined by extraction of drug from the filter and subsequent quantification." | 1.43 | Optimization and Dose Estimation of Aerosol Delivery to Non-Human Primates. ( de Swart, RL; Duprex, WP; Fink, JB; Janssens, HM; MacLoughlin, RJ; van Amerongen, G, 2016) |
| "Conclusively, in carefully preselected COPD patients, bronchodilation/PEEPe exhibits additive benefits." | 1.33 | The effects of nebulized salbutamol, external positive end-expiratory pressure, and their combination on respiratory mechanics, hemodynamics, and gas exchange in mechanically ventilated chronic obstructive pulmonary disease patients. ( Armaganidis, A; Mentzelopoulos, SD; Roussos, C; Tzoufi, M, 2005) |
| "Clenbuterol treatment further reduced bone mineral density." | 1.33 | Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. ( Arlettaz, A; Benhamou, CL; Bonnet, N; Brunet-Imbault, B; Collomp, K; Courteix, D; Horcajada, MN; Richard, O; Vico, L, 2005) |
| "Body weight was not significantly changed by salbutamol treatment but heart and kidney weights (relative to body weight) were significantly increased." | 1.30 | Changes in taurine levels in response to repeated administration of the beta 2-agonist salbutamol in lambs. ( Bastos, ML; Carvalho, F; Ferreira, MA; Mendes, ME; Remião, F; Soares, ME; Timbrell, JA, 1997) |
| "Thus clenbuterol was more potent than salmeterol when given by this route of administration." | 1.29 | Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration. ( Moore, NG; Pegg, GG; Sillence, MN, 1994) |
| "Desipramine-treated rats did not learn the task in contrast to control animals." | 1.28 | Effects of desipramine on rat behavior are prevented by concomitant treatment with ethanol. ( Rommelspacher, H; Widjaja, S; Wolffgramm, J, 1989) |
| "A dose-response study of the effect of naloxone on schedule-induced drinking confirmed that this type of drinking is resistant to the opiate antagonist at doses which depressed drinking induced by water-deprivation, hypertonic saline and salbutamol." | 1.27 | The effect of naloxone on schedule-induced and other drinking. ( Singer, G; Wallace, M; Willis, G, 1984) |
| "Fifty-six male patients with pulmonary emphysema were followed for a minimum period of three years (range 3-13), to observe the effects of smoking and smoking withdrawal." | 1.26 | The influence of cigarette smoking and its withdrawal on the annual change of lung function in pulmonary emphysema. ( Bellamy, D; Dowd, DE; Hugh-Jones, P; Hughes, JA; Hutchison, DC; Ryan, KC, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (21.21) | 18.7374 |
| 1990's | 19 (57.58) | 18.2507 |
| 2000's | 3 (9.09) | 29.6817 |
| 2010's | 4 (12.12) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koch, S | 1 |
| Ahn, JR | 1 |
| Koehle, MS | 1 |
| MacLoughlin, RJ | 1 |
| van Amerongen, G | 1 |
| Fink, JB | 1 |
| Janssens, HM | 1 |
| Duprex, WP | 1 |
| de Swart, RL | 1 |
| Rotta, ET | 1 |
| Amantéa, SL | 1 |
| Froehlich, PE | 1 |
| Becker, A | 1 |
| Yeh, KH | 1 |
| Skowronski, ME | 1 |
| Coreno, AJ | 1 |
| Seitz, RE | 1 |
| Villalba, KD | 1 |
| Dickey-White, H | 1 |
| McFadden, ER | 1 |
| Tzoufi, M | 1 |
| Mentzelopoulos, SD | 1 |
| Roussos, C | 1 |
| Armaganidis, A | 1 |
| Bonnet, N | 2 |
| Benhamou, CL | 2 |
| Brunet-Imbault, B | 2 |
| Arlettaz, A | 2 |
| Horcajada, MN | 2 |
| Richard, O | 1 |
| Vico, L | 1 |
| Collomp, K | 2 |
| Courteix, D | 2 |
| Dusseau, JW | 1 |
| Hutchins, PM | 1 |
| Seo, S | 1 |
| Saeki, K | 1 |
| Wallace, M | 1 |
| Willis, G | 1 |
| Singer, G | 1 |
| Hughes, JA | 1 |
| Hutchison, DC | 1 |
| Bellamy, D | 1 |
| Dowd, DE | 1 |
| Ryan, KC | 1 |
| Hugh-Jones, P | 1 |
| Cartañà, J | 1 |
| Stock, MJ | 1 |
| Carter, WJ | 1 |
| Lynch, ME | 1 |
| Moore, NG | 1 |
| Pegg, GG | 1 |
| Sillence, MN | 1 |
| Oberklaid, F | 1 |
| Mellis, CM | 1 |
| Souëf, PN | 1 |
| Geelhoed, GC | 1 |
| Maccarrone, AL | 1 |
| Oztürk, Y | 1 |
| Yildizoğlu-Ari, N | 1 |
| Altan, VM | 1 |
| Ozçelikay, AT | 1 |
| Bastos, ML | 1 |
| Carvalho, F | 1 |
| Remião, F | 1 |
| Mendes, ME | 1 |
| Ferreira, MA | 1 |
| Soares, ME | 1 |
| Timbrell, JA | 1 |
| Carbó, N | 1 |
| López-Soriano, J | 1 |
| Tarragó, T | 1 |
| González, O | 1 |
| Llovera, M | 1 |
| López-Soriano, FJ | 1 |
| Argilés, JM | 1 |
| Beenen, OH | 1 |
| Batink, HD | 1 |
| Pfaffendorf, M | 1 |
| van Zwieten, PA | 1 |
| Bleecker, ER | 1 |
| Tinkelman, DG | 1 |
| Ramsdell, J | 1 |
| Ekholm, BP | 1 |
| Klinger, NM | 1 |
| Colice, GL | 1 |
| Slade, HB | 1 |
| Kissel, JT | 1 |
| McDermott, MP | 1 |
| Natarajan, R | 1 |
| Mendell, JR | 1 |
| Pandya, S | 1 |
| King, WM | 1 |
| Griggs, RC | 1 |
| Tawil, R | 1 |
| Congleton, J | 1 |
| Muers, MF | 1 |
| Cepero, M | 1 |
| Cubría, JC | 1 |
| Reguera, R | 1 |
| Balaña-Fouce, R | 1 |
| Ordóñez, C | 1 |
| Ordóñez, D | 1 |
| Mohamed, MH | 1 |
| Lima, JJ | 1 |
| Eberle, LV | 1 |
| Self, TH | 1 |
| Johnson, JA | 1 |
| Farias-Silva, E | 1 |
| Grassi-Kassisse, DM | 1 |
| Wolf-Nunes, V | 1 |
| Spadari-Bratfisch, RC | 1 |
| Murphy, RJ | 1 |
| Hartkopp, A | 1 |
| Gardiner, PF | 1 |
| Kjaer, M | 1 |
| Béliveau, L | 1 |
| Olusi, SO | 1 |
| Ojutiku, OO | 1 |
| Jessop, WJ | 1 |
| Iboko, MI | 1 |
| Choo, JJ | 1 |
| Horan, MA | 1 |
| Little, RA | 1 |
| Rothwell, NJ | 1 |
| Guss, S | 1 |
| Portnoy, J | 1 |
| Warriss, PD | 1 |
| Kestin, SC | 1 |
| Rolph, TP | 1 |
| Brown, SN | 1 |
| Rommelspacher, H | 1 |
| Wolffgramm, J | 1 |
| Widjaja, S | 1 |
| Rompala, RE | 1 |
| Darre, MJ | 1 |
7 trials available for albuterol and Body Weight
| Article | Year |
|---|---|
High-Dose Inhaled Salbutamol Does Not Improve 10-km Cycling Time Trial Performance.
Topics: Administration, Inhalation; Adult; Albuterol; Asthma; Athletic Performance; Bicycling; Body Weight; | 2015 |
Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence?
Topics: Acute Disease; Administration, Inhalation; Adolescent; Age Factors; Albuterol; Asthma; Body Weight; | 2010 |
Impact of obesity on the severity and therapeutic responsiveness of acute episodes of asthma.
Topics: Adult; Albuterol; Asthma; Body Mass Index; Body Weight; Emergency Service, Hospital; Hospitalization | 2011 |
A comparison of a bodyweight dose versus a fixed dose of nebulised salbutamol in acute asthma in children.
Topics: Administration, Inhalation; Albuterol; Asthma; Body Weight; Child; Child, Preschool; Double-Blind Me | 1993 |
Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aerosol Propellants; Age Fa | 1998 |
Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group.
Topics: Absorptiometry, Photon; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Body Weight; Female; | 1998 |
Salbutamol effect in spinal cord injured individuals undergoing functional electrical stimulation training.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Biopsy; Body Weight; Combined Modality Therapy; Double-B | 1999 |
26 other studies available for albuterol and Body Weight
| Article | Year |
|---|---|
Optimization and Dose Estimation of Aerosol Delivery to Non-Human Primates.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aerosols; Albuterol; Animals; Body | 2016 |
The effects of nebulized salbutamol, external positive end-expiratory pressure, and their combination on respiratory mechanics, hemodynamics, and gas exchange in mechanically ventilated chronic obstructive pulmonary disease patients.
Topics: Aerosols; Aged; Albuterol; Body Weight; Bronchodilator Agents; Electrocardiography; Female; Function | 2005 |
Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Biomechanical Phenomena; Body Weight; Bone and Bones; | 2005 |
Alteration of trabecular bone under chronic beta2 agonists treatment.
Topics: Adipose Tissue; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Animals; B | 2005 |
Elevated arteriolar adenosine 3',5'-cyclic monophosphate production by SHR.
Topics: 1-Methyl-3-isobutylxanthine; Albuterol; Animals; Arterioles; Blood Pressure; Body Weight; Cyclic AMP | 1982 |
Inhibition of adjuvant arthritis by salbutamol and aminophylline.
Topics: Albuterol; Aminophylline; Animals; Arthritis; Arthritis, Experimental; Body Weight; Cyclic AMP; Male | 1980 |
The effect of naloxone on schedule-induced and other drinking.
Topics: Albuterol; Animals; Body Weight; Drinking Behavior; Drug Administration Schedule; Male; Naloxone; Ra | 1984 |
The influence of cigarette smoking and its withdrawal on the annual change of lung function in pulmonary emphysema.
Topics: Albuterol; Body Weight; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Periodicity; Pulm | 1982 |
Effects of clenbuterol and salbutamol on tissue rubidium uptake in vivo.
Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Albuterol; Animals; Body Weight; Clenbuterol; Ma | 1995 |
Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats.
Topics: Adrenergic beta-Agonists; Aging; Albuterol; Animals; Body Composition; Body Weight; Clenbuterol; Cre | 1994 |
Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration.
Topics: Administration, Oral; Adrenergic beta-Agonists; Albuterol; Animals; Appetite; Body Weight; Clenbuter | 1994 |
Effect of insulin on the decreased beta-adrenergic responses of duodenum and atrium isolated from streptozotocin diabetic rats.
Topics: Albuterol; Animals; Body Weight; Diabetes Mellitus, Experimental; Duodenum; Heart; Heart Atria; In V | 1993 |
Changes in taurine levels in response to repeated administration of the beta 2-agonist salbutamol in lambs.
Topics: Adipose Tissue; Administration, Oral; Adrenergic beta-Agonists; Albuterol; Analysis of Variance; Ani | 1997 |
Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Albuterol; Animals; Body Weight; Cachexia; Clenbuterol; Ea | 1997 |
Beta-andrenoceptors in the hearts of diabetic-hypertensive rats: radioligand binding and functional experiments.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Blood Glucose; Blood Pressure; Body Weight; Cardiotoni | 1997 |
Effect of regular use of high-dose nebulized beta2-agonists on resting energy expenditure, weight, and handgrip strength in patients with chronic airflow limitation.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Body Weight; Energy Me | 1998 |
Plasma and muscle polyamine levels in aerobically exercised rats treated with salbutamol.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Body Weight; Cardiomegaly; Chromatography, High Pressu | 1998 |
Effects of gender and race on albuterol pharmacokinetics.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Black People; Body Fluid Compartments; Body | 1999 |
Stress-induced alteration in the lipolytic response to beta-adrenoceptor agonists in rat white adipocytes.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Body Weig | 1999 |
Plasma and white blood cell ascorbic acid concentrations in patients with bronchial asthma.
Topics: Adult; Age Factors; Albuterol; Ascorbic Acid; Asthma; Body Weight; Cholesterol; Humans; Leukocyte Co | 1979 |
Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation.
Topics: Albuterol; Animals; Body Weight; Clenbuterol; Dose-Response Relationship, Drug; Male; Muscles; Organ | 1992 |
Methotrexate treatment of severe asthma in children.
Topics: Adolescent; Albuterol; Asthma; Beclomethasone; Body Height; Body Weight; Child; Child, Preschool; Cr | 1992 |
The effects of the beta-adrenergic agonist salbutamol on meat quality in pigs.
Topics: Adipose Tissue; Albuterol; Animals; Body Composition; Body Weight; Female; Liver; Meat; Muscle Devel | 1990 |
[From the Veterinary Chief Inspection for Public Health--Action Program Salbutamol (A beta agonist)].
Topics: Albuterol; Animals; Body Weight; Cattle; Drug and Narcotic Control; Netherlands | 1990 |
Effects of desipramine on rat behavior are prevented by concomitant treatment with ethanol.
Topics: 5-Hydroxytryptophan; Adenylyl Cyclases; Albuterol; Animals; Apomorphine; Avoidance Learning; Behavio | 1989 |
Effect of albuterol on oxygen uptake and Na+-K+ ATPase activity of jejunal epithelia and liver in chickens.
Topics: Albuterol; Animals; Body Weight; Chickens; Diet; Fatty Acids, Nonesterified; In Vitro Techniques; In | 1989 |